Log In
Print
BCIQ
Print
Print this Print this
 

DiaPep277

  Manage Alerts
Collapse Summary General Information
Company Evotec AG
DescriptionPeptide composed of 24 amino acids derived from the sequence of heat shock protein 60 (Hsp60)
Molecular Target
Mechanism of ActionImmune modulation
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat latent autoimmune diabetes in adults (LADA); Treat Type I diabetes
Regulatory Designation

Partner

Hyperion Therapeutics Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today